Table 3.
Detective sites | Osteopenia | Osteoporosis | ||||
---|---|---|---|---|---|---|
Variables | Odd ratios (95%CI) | p | Variables | Odd ratios (95%CI) | P | |
Lumber spinea | Age | 1.15 (1.10, 1.21) | < 0.001 | Age | 1.25 (1.18, 1.33) | < 0.001 |
BMI | 0.88 (0.77, 0.99) | 0.038 | BMI | 0.68 (0.57, 0.79) | < 0.001 | |
Serum 25(OH)D3 level | 0.99 (0.98, 1.00) | 0.030 | Serum 25(OH)D3 level | 0.97 (0.96, 0.98) | < 0.001 | |
TNFi usage in the last one year | 0.27 (0.08, 0.84) | 0.027 | ||||
Femoral neckb | Age | 1.17 (1.12, 1.22) | < 0.001 | Age | 1.26 (1.18, 1.36) | < 0.001 |
BMI | 0.85 (0.77, 0.95) | 0.003 | BMI | 0.62 (0.50, 0.75) | < 0.001 | |
Rheumatoid factor concentration | 1.00 (0.99, 1.02) | 0.183 | Serum 25(OH)D3 level | 0.98 (0.96, 0.99) | 0.002 | |
sUA | 1.00 (1.00, 1.01) | 0.068 | ||||
Disease duration | 1.00 (0.89, 1.13) | 0.967 | ||||
Serum phosphate level | 1.87 (0.48, 29.95) | 0.631 | ||||
Total hipc | Age | 1.11 (1.08, 1.15) | < 0.001 | Age | 1.15 (1.10, 1.21 | < 0.001 |
BMI | 0.84 (0.77, 0.92) | < 0.001 | BMI | 0.68(0.58,0.78) | < 0.001 | |
TNFi usage in the last one year | 0.37 (0.14, 0.93) | 0.040 | sUA | 1.01(1.00, 1.01) | 0.001 |
BMI Body mass index, 25(OH)D3 Calcifediol, TNFi Tumor necrosis factor-α inhibitor, sUA Serum uric acid level
aPreselected logistic regression (models A) were optimal for both osteopenia and osteoporosis in lumber spine
bLASSO (models B) were optimal for both osteopenia and osteoporosis in femoral neck (R)
cModel A and B were optimal for osteopenia and osteoporosis respectively in total hip